THAP9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.538590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.114400E-01
Normal-vs-Stage2
5.035500E-02
Normal-vs-Stage3
8.836700E-03
Normal-vs-Stage4
7.536200E-01
Stage1-vs-Stage2
7.106500E-02
Stage1-vs-Stage3
2.213700E-02
Stage1-vs-Stage4
9.872600E-01
Stage2-vs-Stage3
2.001900E-03
Stage2-vs-Stage4
1.367980E-01
Stage3-vs-Stage4
1.870780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.683400E-01
Normal-vs-AfricanAmerican
1.397220E-01
Normal-vs-Asian
1.678450E-01
Caucasian-vs-AfricanAmerican
7.900600E-01
Caucasian-vs-Asian
6.853000E-01
AfricanAmerican-vs-Asian
6.072400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.071790E-01
Normal-vs-Female
2.429800E-01
Male-vs-Female
8.642100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.101200E-01
Normal-vs-Age(41-60Yrs)
3.298000E-01
Normal-vs-Age(61-80Yrs)
1.174800E-01
Normal-vs-Age(81-100Yrs)
3.661500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.721400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.896600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.931200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.719900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.202300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.264000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.574100E-02
Normal-vs-Daily Drinker
1.662430E-01
Normal-vs-Weekly Drinker
5.274000E-02
Normal-vs-Occasional Drinker
4.456000E-01
Normal-vs-Social Drinker
5.383400E-01
Non Drinker-vs-Daily Drinker
5.911600E-01
Non Drinker-vs-Weekly Drinker
9.261800E-01
Non Drinker-vs-Occasional Drinker
7.157600E-02
Non Drinker-vs-Social Drinker
1.366440E-01
Daily Drinker-vs-Weekly Drinker
7.256200E-01
Daily Drinker-vs-Occasional Drinker
2.834600E-01
Daily Drinker-vs-Social Drinker
2.812600E-01
Weekly Drinker-vs-Occasional Drinker
1.729640E-01
Weekly Drinker-vs-Social Drinker
1.857400E-01
Occasional Drinker-vs-Social Drinker
9.155600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.298560E-01
Normal-vs-Grade 2
1.834210E-02
Normal-vs-Grade 3
3.128300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.424500E-02
Grade 1-vs-Grade 3
1.628200E-01
Grade 1-vs-Grade 4
1.298560E-01
Grade 2-vs-Grade 3
4.486800E-01
Grade 2-vs-Grade 4
1.834210E-02
Grade 3-vs-Grade 4
3.128300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.982700E-03
Normal-vs-NonDiabetic
2.285800E-01
Diabetic-vs-NonDiabetic
1.848180E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.449800E-02
Normal-vs-NoPancreatitis
1.476390E-01
Pancreatitis-vs-NoPancreatitis
8.840000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.281400E-01
Normal-vs-N1
5.467700E-02
N0-vs-N1
1.905980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.198600E-01
Normal-vs-TP53-NonMutant
6.564800E-01
TP53-Mutant-vs-TP53-NonMutant
1.257600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
